Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201201085 Principal Investigator: Pluard, Timothy
Title: An Open-Label, Multicenter, Randomized, Phase 2 Study Evaluating the Efficacy and Safety of Ramucirumab (IMC-1121B) Drug Product in Combination with Eribulin Versus Eribulin Monotherapy in Unresectable, Locally-Recurrent or Metastatic Breast Cancer Patients Previously Treated with Anthracycline and Taxane Therapy
Phase: II Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions		 St. Peters
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
This is a study to compare the antitumor activity of ramucirumab (IMC-1121B) and eribulin together versus eribulin alone, in patients with locally-recurrent or metastatic breast cancer.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)